Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Oncology
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| emrelis | AbbVie Inc. (ABBV) |
Phase 3(1)
| Drug | Company |
|---|---|
| abp 234 | AMGEN INC (AMGN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer?
BioSniper tracks 2 drugs in development for Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer across 2 companies.
How many clinical trials target Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer?
There are 1 clinical trial targeting Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer tracked by BioSniper.
Deep-dive into Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis